Preclinical • PARP Biomarker • IO biomarker
|
FLT3 (Fms-related tyrosine kinase 3) • BCL2 (B-cell CLL/lymphoma 2) • ANXA5 (Annexin A5)
|
FLT3-ITD mutation • FLT3 mutation • BCL2 expression • FLT3 wild-type
|
Venclexta (venetoclax) • Xospata (gilteritinib) • azacitidine • daunorubicin • PHI-101